Miguel Perales M.D.(@DrMiguelPerales) 's Twitter Profile Photo

Great kickoff to Asia Pacific Blood and Marrow Transplantation Meeting with local organizing committee, APBMT leadership & traditional Indonesian dance @astct

account_circle
British Journal of Haematology(@BrJHaem) 's Twitter Profile Photo

Outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK improve over time

onlinelibrary.wiley.com/doi/10.1111/bj…

Outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK improve over time 

onlinelibrary.wiley.com/doi/10.1111/bj… 

#lymsm #TCellRx
account_circle
Medby(@medby_org) 's Twitter Profile Photo

Descubre los desafíos en la implementación de la terapia con células CAR-T para el mieloma múltiple. La Dra. Brea Lipe destaca las barreras de acceso y la disparidad en el tratamiento. 🌐💉 ¿Cómo podemos lograr un acceso más equitativo?

account_circle
Medby(@medby_org) 's Twitter Profile Photo

¡Transformación en la Lucha contra el Linfoma!🌟Descubre cómo la terapia CAR-T está cambiando el juego en la hematología. Resultados impresionantes del estudio Zuma-7.
📲 Únete a la revolución en medby.org
  -T Tcells

account_circle
CU Lymphoma Program(@CULymphoma) 's Twitter Profile Photo

Dr. manalikamdar CU Anschutz Division of Hematology contributed to two addn'l abstracts:
- overall survival adjusting for crossover in TRANSFORM: onlinelibrary.wiley.com/doi/10.1002/ho…
- R/R mantle cell lymphoma in TRANSCEND: onlinelibrary.wiley.com/doi/10.1002/ho…
cc CU Cancer Center CU Anschutz Medical Campus

Dr. @mana1981 @CUHematology contributed to two addn'l #17ICML abstracts:
- overall survival adjusting for crossover in TRANSFORM: onlinelibrary.wiley.com/doi/10.1002/ho…
- R/R mantle cell lymphoma in TRANSCEND: onlinelibrary.wiley.com/doi/10.1002/ho…
#lymsm #celltherapy #tcellrx cc @CUCancerCenter @CUAnschutz
account_circle
eJHaem Journal(@e_JHaem) 's Twitter Profile Photo

Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patient

onlinelibrary.wiley.com/doi/10.1002/jh…

Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patient 

onlinelibrary.wiley.com/doi/10.1002/jh… 
#TCellRx #lymsm #PMBCL
account_circle
CU Lymphoma Program(@CULymphoma) 's Twitter Profile Photo

manalikamdar Adam Olszewski MD Michael Wang, MD Dr. manalikamdar is also featured in several oral presentations on in , including liso-cel in follicular lymphoma as well as MCL, and the prognostic implications of ctDNA from the TRANSFORM trial.

@mana1981 @lymphomatic @michaelwangmd Dr. @mana1981 is also featured in several oral presentations on #celltherapy in #lymsm, including liso-cel in follicular lymphoma as well as MCL, and the prognostic implications of ctDNA from the TRANSFORM trial. #tcellrx #ASH23
account_circle
Supriya Gupta, MD(@SupriyaGuptaMD) 's Twitter Profile Photo

for
✅Pros:
for >12 month relapse
Not CD19 dependent
Future CD19 Abs ⬆️
No CRS/ICANS


✅Pros:
⬇️ Transplant toxicity
⏫️ Survival outcomes
Curative⭐️
QoL better

🏆winner is: CAR-T with 86% votes at Mayo Clinic Comprehensive Cancer Center

#BMT for #lymsm
✅Pros:
for >12 month relapse
Not CD19 dependent
Future CD19 Abs ⬆️
No CRS/ICANS

#CART
✅Pros:
⬇️ Transplant toxicity
⏫️ Survival outcomes
Curative⭐️
QoL better

🏆winner is: CAR-T with 86% votes at #MayoCancerNT23 @MayoCancerCare

#bmtsm #mmsm #leuksm #TcellRx
account_circle
British Journal of Haematology(@BrJHaem) 's Twitter Profile Photo

T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails! Joshua Richter, MD, FACP

onlinelibrary.wiley.com/doi/10.1111/bj…

T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails! @JoshuaRichterMD

onlinelibrary.wiley.com/doi/10.1111/bj… #mmsm #bmtsm #TCellRx
account_circle
Medby(@medby_org) 's Twitter Profile Photo

La revolución en el tratamiento del linfoma de alto riesgo está en marcha con el estudio ZUMA-23.
Únete a la comunidad de Medby, donde médicos comparten conocimientos de vanguardia. Regístrate hoy.🌐
Jason Westin, MD FACP Anna Sureda

account_circle
Jordan Gauthier(@drjgauthier) 's Twitter Profile Photo

Dr. Neelapu showing spectacular data including in the CD19 CAR-exposed population: A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (γδ) T Cells in Adults with B-Cell Malignancies tandem.confex.com/tandem/2023/me…

Dr. Neelapu showing spectacular data including in the CD19 CAR-exposed population: A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (γδ) T Cells in Adults with B-Cell Malignancies #tandem23 tandem.confex.com/tandem/2023/me… #TcellRx
account_circle
CU Lymphoma Program(@CULymphoma) 's Twitter Profile Photo

Our lymphoma faculty CU Anschutz Division of Hematology had several manuscripts published concurrently with ASH !
First, Drs. Ajay Major, MD, MBA & manalikamdar published an ASH Education manuscript on bispecific antibodies vs CAR-T in relapsed LBCL. /1
pubmed.ncbi.nlm.nih.gov/38066907/

Our lymphoma faculty @CUHematology had several manuscripts published concurrently with @ASH_hematology #ASH23!
First, Drs. @majorajay & @mana1981 published an ASH Education manuscript on bispecific antibodies vs CAR-T in relapsed LBCL. #lymsm #tcellrx /1
pubmed.ncbi.nlm.nih.gov/38066907/
account_circle
eJHaem Journal(@e_JHaem) 's Twitter Profile Photo

Correspondence from Perriello et al: Polatuzumab-bendamustine-rituximab as bridge to CD19-directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax

onlinelibrary.wiley.com/doi/10.1002/jh…
Università degli Studi di Perugia

Correspondence from Perriello et al: Polatuzumab-bendamustine-rituximab as bridge to CD19-directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 

onlinelibrary.wiley.com/doi/10.1002/jh… 
#lymsm #polatuzumab #TCellRx @UniperugiaNews
account_circle